Navigation Links
Measurement Challenges In Detecting Cancer Biomarkers

Effective control of sexually transmitted diseases (STDs) requires treatment of the sexual partners of infected patients. A new study shows that providing infected men with antibiotics to give their partners is more effective than traditional means of contacting and treating the partners, according to an article in the Sept. 1 issue of Clinical Infectious Diseases, now available online. Men with chlamydia or gonorrhea were more likely to see and talk to their female partners about the STD when given medicine to give to their partners than the men who were simply told to inform their partners of their STD exposure.

Partner referral is the most common method of attempting to control STD spread and recurrence. Health care providers ask STD-infected patients to contact their sexual partners, inform them of their risk for infection, and encourage them to seek medical care. A second method, booklet-enhanced partner referral, also provides the patients with booklets that have referral tear-out cards for distribution to sex partners. The new method, known as patient-delivered partner treatment, gives the patient an antibiotic to offer to his partner.

To compare the efficacy of patient-delivered partner treatment with standard and booklet-enhanced partner referral, the researchers enrolled 977 men from an STD clinic in New Orleans. The men had all had a diagnosis of urethritis due to chlamydia and/or gonorrhea infection, and most reported two or more sex partners. The men were each randomly assigned to one of the three partner treatment arms. Nearly 80 percent of the patients completed a follow-up interview four weeks later, and 38 percent were re-tested for STDs.

The researchers found that about 70 percent of men in the patient-delivered partner treatment arm gave the intervention to their partners (giving antibiotics), compared with 58 percent of men in the booklet-enhanced arm (giving tear-out referral cards), and 48 percent of men in the standard p
'"/>

Source:


Page: 1 2 3

Related biology news :

1. Grand Challenges in Global Health initiative funds Yale project
2. Detecting explosives with honeybees
3. Detecting microalgae in coastal waters
4. Detecting poisons in nectar is an odour-ous task for honeybees
5. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
6. Jump-starting T Cells In Skin Cancer
7. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
8. Fox Chase Cancer Center scientists identify immune-system mutation
9. Breakthrough Microarray-based Technology for the Study of Cancer
10. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
11. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery

Post Your Comments:
(Date:11/23/2009)...research suggests that a common oral bacterium may...t by Nichols et al, "Unique Lipids from a Common H...ds Capable of Enhancing Autoimmunity," appears in ...f Pathology . , Multiple sclerosis (MS), a disea...pinal cord, affects nearly 1 in 700 people in the ...
(Date:11/23/2009)..., 2009 -- A USDOE and USDA study concluded that 50...d cropland pasture could be converted from current... as switchgrass, from which biomass could be harve...viable production of a perennial grass monoculture...removed annually is expected to require nitrogen f...
(Date:11/23/2009)... California biomedical engineer and cardiologist T...elp clinicians distinguish cardiac emergencies req...ageable with drugs and lifestyle change. , Angio...arteries feeding the heart, offer an inside view o...ssels, often revealing deposits of a dangerous fat...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Food Stamps Help Stave Off Hunger in Many U S Homes 60535 1Food Stamps Help Stave Off Hunger in Many U S Homes 60535 2Adapting space industry technology to treat breast cancer 60532 1Adapting space industry technology to treat breast cancer 60532 2Adapting space industry technology to treat breast cancer 60532 3Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 1Innovative R 26amp 3BD prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award 10602 2
...e, may hold a key to defeating another implacable ...in Philadelphia have used a drastically weakened r...mals, in essence, vaccinating them against an AIDS...accine ?which doesn’t protect against infection ?p... 1, 2007 in the Journal of Infectious Diseases, th...
...s during a recent influenza B epidemic in Japan sh...tance to the drugs, according to a study in the Ap...vir and oseltamivir, which are a type of drugs kno...e against influenza and are used extensively. Ther... oseltamivir-resistant type A viruses, but similar...
...iginates from the electrical signals emitted by di.... At this fundamental level, scientists struggle t...ols to understand what,s going wrong in patients w...ease. New Stanford-led research published in the A...rectly control brain cell activity with light. It ...
Other Biology News:Jefferson scientists find rabies-based vaccine could be effective against HIV 2Study suggests some drug resistance to influenza B medications 2Study suggests some drug resistance to influenza B medications 3A 'traffic light' for neurons means 'go' for improving brain research 2A 'traffic light' for neurons means 'go' for improving brain research 3A 'traffic light' for neurons means 'go' for improving brain research 4
(Date:11/24/2009)...cal Abstracts Service (CAS), the global expert on ...office is now the world,s leading producer of pate...led Japan,s patent office, the World Intellectual ...s Patent and Trademark Office (USPTO) for more tha...2006, and exceeded Japan for the first time on a m...
(Date:11/23/2009)...mensional carbon layer in which the carbon atoms a...oneycomb. Carbon nanotubes are rolled-up sheets of... graphite. Graphene boasts some very special chara...ellent thermal conductor, and reconciles such conf... addition, graphene is impermeable to gases, which...
(Date:11/23/2009)...re/--ImmuneDesignC or p.(IDC)announcedtodaythatDr....Carterhasasuccessfultrackrec or dinbiotechnologyex...ficeratZymoGenetics,inSeattle,WAandChiefScientific...Photo: http://www.newscom.com/cgi-bin/prnh/2009112...efExecutiveOfficercommented,"Iamdelightedtowelcome...
(Date:11/20/2009)... , , , , , , , ... A team of scientists from Washington University...ing Harbor Laboratory and Iowa State University ha... , Click here for more information. ... , , , , , , , ...
Breaking Biology Technology:China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...ed Starfish,Ventures announced today the successfu...85 million, the largest venture capital fundraisin...Sciences and Cleantech,companies., The success of...ntures,and an endorsement of Australia,s ability t...hat, with the right support, can be transformed in...
...peutics,Inc. (Nasdaq: TPTX ) today announced that...m as the Company,s Chief Executive Officer and as ...Graham had been serving as,the Company,s acting Ch...Ev has done an impressive job as acting CEO in man... platform for the future," said Peter Davis,Chairm...
...ed today,that the technology used in the CellSearc...Cs) was ranked as the top medical innovation for 2...lty academic medical center. The,ranking is based ...t on,health care next year., The prestigious annu...s,by a panel of Cleveland Clinic physicians. The l...
Other Biology Technology:Starfish Ventures Closes Australia's Largest Venture Capital Fund With $185 Million Tech Fund 2TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors 2TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors 3Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009 2Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009 3
Goat Anti-Sarcosine Oxidase Polyclonal Antibody, HRP Conjugated from Abcam
Mouse Anti-Rat ICAM Monoclonal Antibody, PE Conjugated from Antigenix America Inc.
Mouse Anti-C2 Monoclonal Antibody, Unconjugated, Clone 050-04 from Abcam
Mouse Anti-5-Methylcytosine Monoclonal Antibody, Unconjugated, Clone 33D3 from Eurogentec
Biology Products: